US Stock MarketDetailed Quotes
ELAB Elevai Labs
- 2.181
- -0.319-12.77%
Trading Nov 27 12:55 ET
6.70MMarket Cap-98P/E (TTM)
2.600High2.045Low731.42KVolume2.340Open2.500Pre Close1.68MTurnover24.20%Turnover RatioLossP/E (Static)3.07MShares778.00052wk High0.78P/B6.59MFloat Cap2.04552wk Low--Dividend TTM3.02MShs Float848.840Historical High--Div YieldTTM22.20%Amplitude2.045Historical Low2.293Avg Price1Lot Size
About Elevai Labs Company
Elevai Labs, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed and Jordan R. Plews in 2020 and is headquartered in Newport Beach, CA.
Company Profile
SymbolELAB
Company NameElevai Labs
Listing DateNov 21, 2023
Issue Price4.00
Founded2020
CEOMr. Graydon Bensler
MarketNASDAQ
Employees18
Fiscal Year Ends12-31
Address120 Newport Center Drive,Suite 250
CityNewport Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92660
Phone1-866-794-4940
Websitehttp://elevaiskincare.com
Company Executives
- Name
- Position
- Salary
- Graydon Bensler
- Chief Executive Officer, Chief Financial Officer, Principle Accounting Officer and Director
- --
- Dr. Jordan R. Plews, Pd.D
- President and Director; Chief Executive Officer of Elevai Skincare Inc and Elevai Biosciences Inc
- 200.00K
- Braeden Lichti
- Non-Executive Chairman of the Board
- --
- George Kovalyov
- Independent Director
- --
- Juliana L. Daley
- Independent Director
- --
- Jeffrey Owen Parry BA,MBA
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data